Clinical Trials Browser

Breast Cancer Recurrent × S 1 (combination) × Clear all

NCT02947061 2016-10-31

S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer

Phase 2 Unknown

Breast Cancer Recurrent